2022
DOI: 10.1016/j.phymed.2022.154324
|View full text |Cite
|
Sign up to set email alerts
|

A review on computational approaches that support the researches on traditional Chinese medicines (TCM) against COVID-19

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(3 citation statements)
references
References 179 publications
0
3
0
Order By: Relevance
“…The active site of M pro is an extensively studied drug target situated in the crevice between structural domains 2 and 3 . This active site encompasses five crucial subsites for substrate recognition: S1′, S1, S2, S4. , Numerous small molecules targeting the active site of M pro have been discovered. , Among them, Ensitreivir stands out as the first orally administered clinical candidate, belonging to the category of noncovalent nonpeptidic inhibitors. , Structural modifications of small-molecule inhibitors against this target have been a thriving area of research, aiming to circumvent patents, enhance drug activity, or reduce resistance arising from viral mutations. …”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…The active site of M pro is an extensively studied drug target situated in the crevice between structural domains 2 and 3 . This active site encompasses five crucial subsites for substrate recognition: S1′, S1, S2, S4. , Numerous small molecules targeting the active site of M pro have been discovered. , Among them, Ensitreivir stands out as the first orally administered clinical candidate, belonging to the category of noncovalent nonpeptidic inhibitors. , Structural modifications of small-molecule inhibitors against this target have been a thriving area of research, aiming to circumvent patents, enhance drug activity, or reduce resistance arising from viral mutations. …”
Section: Resultsmentioning
confidence: 99%
“…51,52 Numerous small molecules targeting the active site of M pro have been discovered. 53,54 Among them, Ensitreivir stands out as the first orally administered clinical candidate, belonging to the category of noncovalent nonpeptidic inhibitors. 43,54 Structural modifications of small-molecule inhibitors against this target have been a thriving area of research, aiming to circumvent patents, enhance drug activity, or reduce resistance arising from viral mutations.…”
Section: Pocket Scoring and Automatic Pocketmentioning
confidence: 99%
“…1 In addition, network pharmacology integrates the interaction into a network and analyzes the action of traditional Chinese medicine (TCM) from a systematic perspective. 2 Meanwhile, some problems such as the difficulty of data integration for network pharmacology remain to be overcome. The signed random walk with restart (SRWR) has been developed to simulate the propagation of activation or inhibition effects of the drug on the signaling network.…”
Section: Introductionmentioning
confidence: 99%